All stock lists
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
$10.64+$0.02 (+0.19%)
Market cap
$898M
Insider Score
Health Score
Analyst consensus
Listed since
Mar 23, 2016
Website
Insider Score
82/ 100
CRVS Insider Score
Bullish4 qualifying trades · 1 insider · $50.48K bought in the last 90 days
Corvus Pharmaceuticals, Inc. Executive Compensation
Reading the latest SEC DEF 14A proxy…
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.